Other content tagged: news research
Anti-VEGF drug ranibizumab: A new treatment option against retinopathy of prematurity?
Retinopathy of prematurity (ROP) is an eye disease that only occurs in very premature babies (usually preterm babies born before the 31st week or born with a birthweight below 1250 g). With ROP, unwanted blood vessels grow on the retina in the back of the baby’s eye that can lead to serious eye problems and even blindness. There are two main treatment approaches, laser surgery and anti-VEGF injections. The latter aims at inhibiting VEGF, the growth factor mainly responsible for…
Read more
Preterm babies are less likely to form romantic relationships in adulthood
Adults who were born preterm (under 37 weeks gestation) are less likely to have a romantic relationship, a sexual partner and experience parenthood than those born full term. The meta-analysis by researchers at the University of Warwick with data from up to 4.4 million adult participants showed that those born preterm are 28% less likely to ever be in a romantic relationship. A study of up to 4.4m adult participants has shown that those who were born preterm (under 37…
Read more
Series of RECAP cohorts – part 4: the NTNU Low Birth Weight Life study from Norway
In our series about cohorts of the EU-funded project „Research on European Children and Adults born Preterm“ (RECAP preterm), we presented the Project Extreme Prematurity (PEP) from Norway. We are thrilled to share a second example from Norway with you, the Low Birth Weight Life study of the Norwegian University of Science and Technology (NTNU). Principal investigator Kari Anne I. Evensen, Associate Professor at the NTNU, told us what this study is all about. The NTNU Low Birth Weight in…
Read more
The RECAP preterm project: Steering committee meeting in Leiden
From 1 to 3 July 2019, the steering committee of the RECAP preterm (Research on European Children and Adults born Preterm) project met in Leiden in Southern Netherlands. All work package leaders, in total more than 20 participants, joined the meeting. As the half-time mark of the project has been reached, the meeting participants took the opportunity to look back at was has been reached so far and defined milestones for the coming…
Read more
How the ESPR seeks to improve medical care and clinical practice in Paediatrics
Within the monthly topic ‘Medical care and clinical practice’ of our campaign 11 Months - 11 Topics, we present you the European Society for Paediatric Research (ESPR), an organisation which has been at the forefront of Paediatric medical care and innovation since 1958. As one of the oldest and most prolific Paediatric research societies in Europe, the ESPR co-organises annual conferences (the joint European Neonatal Societies’ Congress and European Academy of Paediatric Societies’ Congress), supports investigators with research grants, runs a…
Read more
Expert feedback wanted: new EMA guideline drafted for public consultation
The European Medicines Agency (EMA) released a draft guideline for public consultation on the quality requirements for medical devices in human medicines that include a medical device, known as drug-device combinations. The guideline covers devices that are necessary for the administration, dosing or use of the medicine. They can be integral, co-packaged or referred to in the product information of the medicine but obtained separately. It is intended that this guideline will increase transparency and consistency of information in regulatory…
Read more
Improving parents’ and infants’ experiences and outcomes of neonatal care: invitation to the 7th SCENE Symposium
SCENE (Separation and Closeness Experiences in the Neonatal Environment) is a multi-disciplinary group of international professionals that aims to improve parents’ and infants’ experiences and outcomes of neonatal care. The SCENE research group warmly invites all SCENE study group members and potential new collaborators to participate in the 7th SCENE Symposium which will be held in Budapest, Hungary, November 8th- 9th, 2019. The registration deadline is October 15th, 2019. Please register through e-mail to Anna Axelin (anna.axelin@utu.fi). Please note that…
Read more
Series of RECAP cohorts – part 3: the Project Extreme Prematurity (PEP) from Norway
We are delighted to present you a third example of our series about cohorts of the EU-funded project „Research on European Children and Adults born Preterm“ (RECAP preterm): the Project Extreme Prematurity (PEP) from Norway. Find out more in this article by the researchers Maria Vollsæter, Thomas Halvorsen, and Trond Markestad. The purpose of Project Extreme Prematurity (PEP) is to study short and long-term health and well-being in children born extremely prematurely. Survival after preterm birth is now the rule…
Read more
Research on Bronchopulmonary dysplasia (BPD) in preterm babies
Interview with Prof Christoph Bührer, Medical Director Department of Neonatology, Charité Berlin Within our monthly topic of medical care and clinical practice, we talked to Prof Bührer about his work on the study “Sustained inflations and avoiding mechanical ventilation to prevent death or bronchopulmonary dysplasia: a meta-analysis”1. It is about meta-analysis of randomised controlled trials (RCTs) in preterm infants. It showed that delivery room strategies to avoid mechanical ventilation reduced bronchopulmonary dysplasia, whereas sustained inflations had no effect and may…
Read more
